Skip to main content
. 2019 Dec 16;25:9609–9617. doi: 10.12659/MSM.919654

Figure 2.

Figure 2

Long noncoding RNA FTX (lnc-FTX) expression, cell viability, myocardial beat frequency, and cell surface area in the study groups. (A) Expression of long noncoding RNA FTX (lnc-FTX) in the study groups. *** P<0.001 vs. the control group. ### P<0.001 vs. the miRNA-NC group. (B) The cell viability in the study groups at 24 h, 48 h, and 72 h. * P<0.05, *** P<0.001 vs. the control group. # P<0.05, ### P<0.001 vs. pcDNA+the angiotensin II (Ang II) group. (C) The myocardial beat frequency in the study groups. ** P<0.01 vs. control group; ## P<0.01 pcDNA (72 h)+the Ang II group (24 h). (D) Cell surface area in the study groups. *** P<0.001 vs. the control (72 h) group; ### P<0.001 vs. pcDNA (72 h)+the Ang II group (24 h).